Woodline Partners’s Vigil Neuroscience VIGL Stock Holding History

Woodline Partners’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-653,619	Closed	-$5.2M	–	1058
2025 Q2	$5.2M	Buy	653,619 +400,820	+159%	+$1.8M	0.03%	552
2025 Q1	$450K	Sell	252,799 -235,957	-48%	-$530K	﹤0.01%	835
2024 Q4	$831K	Buy	488,756 +344,614	+239%	+$1.02M	0.01%	786
2024 Q3	$490K	Sell	144,142 -62,472	-30%	-$231K	﹤0.01%	538
2024 Q2	$826K	Buy	+206,614	New	+$707K	0.01%	473

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Woodline Partners's VIGL Position: Q3 2025 in Review

Woodline Partners sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 653,619 shares — an estimated $5.2M sold.

Woodline Partners first reported a position in VIGL in Q2 2024 and held it in 5 quarters. The position peaked at $5.2M in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Woodline Partners reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Woodline Partners sold 653,619 Vigil Neuroscience shares in Q3 2025, an estimated $5.2M.
Woodline Partners first reported a position in Vigil Neuroscience in Q2 2024 and held it in 5 quarters.
Woodline Partners's Vigil Neuroscience position peaked at $5.2M in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Woodline Partners's 13F filing for Q3 2025, filed 14 Nov 2025.